{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:38:57Z","timestamp":1762900737314,"version":"3.41.2"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2024-I2M-C&amp;T-B-014"],"award-info":[{"award-number":["2024-I2M-C&amp;T-B-014"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Phospholipase C gamma 2 (<jats:italic>PLCG2<\/jats:italic>) gene mutations might cause PLCG2-associated antibody deficiency and immune dysregulation (PLAID)\/autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) syndrome. They are two forms of autosomal-dominant immune dysregulation (ID). APLAID patients are usually characterized by skin lesions, pulmonary involvement, and musculoskeletal, ophthalmic, and gastrointestinal tract symptoms, but unlike PLAID patients, these patients do not present with cold urticaria or autoimmunity. Here, we report a 25-year-old man with B-cell lymphopenia, pulmonary bullae, recurrent sinopulmonary infections, and cutis laxa but without cold-induced urticaria. Anti-nuclear antibodies were negative. Trio whole-genome sequencing revealed a <jats:italic>de novo<\/jats:italic> heterozygous <jats:italic>PLCG2<\/jats:italic> gene (NM_002661.5) variant c.3417_3419del, p.E1139del, located on chromosome chr16-81973600-81973602. Our findings expand the variety of clinical and genetic phenotypes for APLAID and suggest that this variant would be meaningful.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1556372","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T10:40:17Z","timestamp":1742294417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: de novo in-frame deletion in PLCG2 gene: a case report of B-cell lymphopenia, pulmonary bullae, and cutis laxa"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoqi","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100905","article-title":"The role of PLCgamma2 in immunological disorders, cancer, and neurodegeneration","volume":"297","author":"Jackson","year":"2021","journal-title":"J Biol Chem"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-440X(97)80122-4","article-title":"Protein kinase C and phospholipase C: bilayer interactions and regulation","volume":"7","author":"Hurley","year":"1997","journal-title":"Curr Opin Struct Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(01)00252-2","article-title":"Regulation of phospholipase C-gamma 2 via phosphatidylinositol 3-kinase in macrophages","volume":"14","author":"Hiller","year":"2002","journal-title":"Cell Signal"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.019265","article-title":"Characterization of phospholipase C gamma enzymes with gain-of-function mutations","volume":"284","author":"Everett","year":"2009","journal-title":"J Biol Chem"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.08.006","article-title":"A hypermorphic missense mutation in PLCG2, encoding phospholipase Cgamma2, causes a dominantly inherited autoinflammatory disease with immunodeficiency","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667430","article-title":"Case report: A rare case of autoinflammatory phospholipase C\u03b32 (PLC\u03b32)-associated antibody deficiency and immune dysregulation complicated with gangrenous pyoderma and literature review","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.08.036","article-title":"PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants","volume":"153","author":"Baysac","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02863","article-title":"Novel PLCG2 mutation in a patient with APLAID and cutis laxa","volume":"9","author":"Neves","year":"2018","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10875-020-00794-7","article-title":"Severe autoinflammatory manifestations and antibody deficiency due to novel hypermorphic PLCG2 mutations","volume":"40","author":"Mart\u00edn-Nalda","year":"2020","journal-title":"J Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154369","article-title":"Variant in the PLCG2 gene may cause a phenotypic overlap of APLAID\/PLAID: case series and literature review","volume":"11","author":"Welzel","year":"2022","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.565099","article-title":"Single-center overview of pediatric monogenic autoinflammatory diseases in the past decade: a summary and beyond","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00731-3","article-title":"A germline mutation in the C2 domain of PLC\u03b32 associated with gain-of-function expands the phenotype for PLCG2-related diseases","volume":"40","author":"Novice","year":"2020","journal-title":"J Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15918","article-title":"Expanding the clinical features of autoinflammation and phospholipase Cgamma2-associated antibody deficiency and immune dysregulation by description of a novel patient","volume":"33","author":"Moran-Villasenor","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2020.01.008","article-title":"A new report of autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) with a homozygous pattern from Iran","volume":"221","author":"Khabbazi","year":"2020","journal-title":"Immunol Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082100","article-title":"PLC-gamma2 is essential for formation and maintenance of memory B cells","volume":"206","author":"Hikida","year":"2009","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.38961","article-title":"Connecting two pathways through Ca2+ signaling: NLRP3 inflammasome activation induced by a hypermorphic PLCG2 mutation","volume":"67","author":"Chae","year":"2015","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1556372\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T10:40:19Z","timestamp":1742294419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1556372\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":17,"alternative-id":["10.3389\/fimmu.2025.1556372"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1556372","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"article-number":"1556372"}}